Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults

NICE technology appraisal guidance [TA157] Published date:

Dabigatran etexilate is recommended as a possible treatment to reduce the risk of venous thromboembolism in adults who have surgery to replace their hip or knee joint.

Get involved